Cite
HARVARD Citation
Lv, H. et al. (2022). Immunogenicity and safety of the 9-valent human papillomavirus vaccine in Chinese females 9–45 years of age: A phase 3 open-label study. Vaccine. 40 (23), pp. 3263-3271. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lv, H. et al. (2022). Immunogenicity and safety of the 9-valent human papillomavirus vaccine in Chinese females 9–45 years of age: A phase 3 open-label study. Vaccine. 40 (23), pp. 3263-3271. [Online].